HOFSETH BIOCARE ASA: årsregnskap 2019 vs 2018
Grew 17% on revenue
approved 2020-03-20; registry 2020-07-09; journal 2020 560767
Summary
What changed
Comparing Årsregnskap 2019 with 2018 for HOFSETH BIOCARE ASA. Revenue 49.88m NOK → 58.50m NOK (+17.3%). Net result -84.77m NOK → -89.21m NOK. Equity 87.45m NOK → 118.79m NOK.
On the constructive side: revenue rose; equity strengthened; cash rose. Pressures included: operating result weakened; net result weakened.
Also worth watching: book investments changed. All figures are taken from the published annual accounts for HOFSETH BIOCARE ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 49.88m NOK to 58.50m NOK (+17.3% YoY). Calculated
-
↑
Equity strengthened
Book equity 87.45m NOK → 118.79m NOK (equity ratio 672723076.9% → 452.1%). Calculated
-
↑
Cash rose
Bank deposits 45.29m NOK → 92.23m NOK (+103.6% YoY). Calculated
-
↑
Current ratio back above 1×
Current ratio 0.54× → 1.70×. Calculated
-
↑
Owners injected capital
Paid-in equity rose 294.8k NOK → 326.6k NOK (+31.8k NOK). Reported fact
What deteriorated
-
↓
Operating result weakened
Operating result -70.59m NOK → -75.93m NOK (op. margin -141.5% → -129.8%). Calculated
-
↓
Net result weakened
Net result -84.77m NOK → -89.21m NOK (net margin -169.9% → -152.5%). Calculated
Things to notice
-
·
Book investments changed
Investment / intangible book value 25.31m NOK → 21.32m NOK. Reported fact